Screener
Evolent Health, Inc. EVH Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 17.2%+0.9pp | 20.2%+4.9pp | 21.3%+6.9pp | 18.4%+2.5pp | 16.4%-2.2pp | |
| Operating margin | -20.4%-18.7pp | -22.2%-21.0pp | -21.9%-20.3pp | -1%+0.8pp | -1.7%+0.2pp | |
| Net margin | -24.1%-18.1pp | -26.3%-21.7pp | -28.5%-26.1pp | -6.2%-3.3pp | -5.9%-2.8pp | |
| Returns | ||||||
| Return on equity | -79%-65.6pp | -74.6%-63.6pp | -75.5%-69.5pp | -13.6%-6.9pp | -13.4%-6.4pp | |
| Return on invested capital | -30.1%-27.8pp | -29.9%-28.1pp | -28.6%-26.1pp | -1.2%+1.5pp | -2.4%+0.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.1× | 0.8×-0.1× | 0.8×-0.1× | 0.8×-0.1× | 0.9×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×+0.2× | 1.3×+0.3× | 1.3×+0.5× | 1.3×+0.3× | 1×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 2.5×+1.6× | 2.5×+1.6× | 2.4×+1.7× | 1.3×+0.7× | 1×+0.3× | |
| Per Share | ||||||
| Book value per share | $3.41-56.0% | $3.54-56.3% | $3.64-58.4% | $7.38-18.3% | $7.73-15.9% | |
| Valuation | ||||||
| Market capitalization | $446.58M-58.2% | $254.54M-76.9% | $446.4M-65.5% | $981.12M-70.2% | $1.25B-43.1% | |
| Price / sales | 0.2×-0.3× | 0.1×-0.3× | 0.2×-0.3× | 0.5×-0.9× | 0.6×-0.4× | |
| Price / book | 1.2×0.0× | 0.6×-0.5× | 1.1×-0.2× | 1.2×-2.0× | 1.4×-0.7× |
FAQ
- What are Evolent Health, Inc.'s profit margins?
- Evolent Health, Inc. (EVH) runs a 17.2% gross margin and a -20.4% operating margin, with a -24.1% net margin.
- Where do Evolent Health, Inc.'s ratios come from?
- Every ratio is computed from Evolent Health, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
